МЕСТО ПСИХИЧЕСКОЙ ПАТОЛОГИИ В СТРУКТУРЕ ПРЕЖДЕВРЕМЕННОЙ НЕДОСТАТОЧНОСТИ ЯИЧНИКОВ
Обзорная статья
Дата публикации: июня 7, 2024
Ключевые слова
недостаточность
яичники
яичники
Как цитировать
Кочергина М. С., Самушия М. А., Диланян Т. Г., Юренева С. В., Титова В. В., Харитоненкова Е. Ю. МЕСТО ПСИХИЧЕСКОЙ ПАТОЛОГИИ В СТРУКТУРЕ ПРЕЖДЕВРЕМЕННОЙ НЕДОСТАТОЧНОСТИ ЯИЧНИКОВ // Кремлевская медицина. Клинический вестник. 2024. Т. № 2. С. 77-81.
Аннотация
Преждевременная недостаточность яичников (ПНЯ) – симптомокомплекс, характеризующийся ранним истощением овариального резерва и развитием аменореи у женщин в возрасте до 40 лет, а также повышением уровня гонадотропных гормонов и снижением концентрации эстрадиола. ПНЯ, несомненно, является не только патофизиологической проблемой, но и оказывает существенное влияние на психоэмоциональное состояние женщин, а также снижает качество жизни пациенток. В последние годы возрастает интерес к изучению роли психогенного фактора в качестве пускового механизма ПНЯ и его влияния на течение болезни в целом.Литература
1. Li M. et al. The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis // Climacteric. – 2023. – V. 26. – No 2. – P. 95–102. DOI: 10.1080/13697137.2022.2153033.
2. Golezar S. et al. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis // Climacteric. – 2019. – V. 22. – No 4. – P. 403–411. DOI: 10.1080/13697137.2019.1574738.
3. Дубкова Е.А. и др. Влияние комбинированных оральных контрацептивов на уровень антимюллерова гормона в патогенезе преждевременного истощения яичников // Journal of Siberian Medical Sciences. – 2014. – № 3. – С. 75. [Dubkova E.A. et al. Influence of combined oral contraceptives on the hormone anti-mullerian level in pathogenesis of premature deterioration of ovaries // Journal of Siberian Medical Sciences. – 2014. – No 3. – P. 75. In Russian].
4. Luborsky J.L. et al. Premature menopause in a multi‐ethnic population study of the menopause transition // Human Reproduction. – 2003. – V. 18. – No 1. – P. 199–206. DOI: 10.1093/humrep/deg005.
5. Van Kasteren Y.M. et al. Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease? // Human Reproduction. – 1999. – V. 14. – No 10. – P. 2455–2459. DOI: 10.1093/humrep/14.10.2455.
6. Семенова Е.В. и др. Этиология женского бесплодия // Современные проблемы медицины и естественных наук. – 2018. – С. 79–83. [Semenova E.V. et al. Ethiology of female infertility // Modern problems of medicine and natural science. – 2018. – P. 79–83. In Russian].
7. Машина М.А. и др. Проблемы изменения репродуктивного поведения и реализации репродуктивной функции // Лечащий врач. – 2014. – № 12. – С. 22–22. [Mashina M.A. et al. Problems of changing reproductive behavior and implementation of reproductive function // Lechaschi vrach. – 2014. – No 12. – P. 22–22. In Russian].
8. Schmidt P.J. et al. Depression in women with spontaneous 46, XX primary ovarian insufficiency // The Journal of Clinical Endocrinology & Metabolism. – 2011. – V. 96. – No 2. – P. E278–E287. DOI: 10.1210/jc.2010-0613.
9. Mann E. et al. Psychosocial adjustment in women with premature menopause: a cross-sectional survey // Climacteric. – 2012. – V. 15. – No 5. – P. 481–489. DOI: 10.3109/13697137.2011.647841.
10. Liao K.L.M. et al. Premature menopause and psychological well-being // Journal of Psychosomatic Obstetrics & Gynecology. – 2000. – V. 21. – No 3. – P. 167–174. DOI: 10.3109/01674820009075624.
11. Deeks A.A. et al. Premature menopause: a comprehensive understanding of psychosocial aspects // Climacteric. – 2011. – V. 14. – No 5. – P. 565–572. DOI: 10.3109/13697137.2011.566390.
12. Домнина О.Л. и др. Анализ экономической значимости психических расстройств // Научные проблемы водного транспорта. – 2018. – No 56. – С. 139–148. [Domnina O.L. et al. Analysis of economic significance of mental disorders // Russian Journal of Water Transport. – 2018. – No 56 – P. 139–148. In Russian].
13. Eshre Guideline Group on POI et al. ESHRE Guideline: management of women with premature ovarian insufficiency // Human Reproduction. – 2016. – V. 31. – No 5. – P. 926–937. DOI: 10.1093/humrep/dew027.
14. Yorgun H. et al. The cardiovascular effects of premature ovarian failure // International Journal of Cardiology. – 2013. – V. 168. – No 1. – С. 506–510. DOI: 10.1016/j.ijcard.2012.09.197.
15. Podfigurna-Stopa A. et al. Premature ovarian insufficiency: the context of long-term effects // Journal of Endocrinological Investigation. – 2016. – V. 39. – P. 983–990. DOI: 10.1007/s40618-016-0467-z.
16. Anagnostis P. et al. Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis // European Journal of Endocrinology. – 2019. – V. 180. – No 1. – P. 41–50. DOI: 10.1530/EJE-18-0602.
17. Lana M.B.P. et al. What is really responsible for bone loss in spontaneous premature ovarian failure? A new enigma // Gynecological Endocrinology. – 2010. – V. 26. – No 10. – P. 755–759. DOI: 10.3109/09513590.2010.487599.
18. Pimple P. et al. Psychological distress and subsequent cardiovascular events in individuals with coronary artery disease // Journal of the American Heart Association. – 2019. – V. 8. – No 9. – P. e011866. DOI: 10.1161/JAHA.118.011866.
19. Tsolaki M. et al. Severe psychological stress in elderly individuals: a proposed model of neurodegeneration and its implications // American Journal of Alzheimer's Disease & Other Dementias®. – 2009. – V. 24. – No 2. – P. 85–94. DOI: 10.1177/1533317508329813.
20. Prasad S. et al. Impact of stress on oocyte quality and reproductive outcome //Journal of Biomedical Science. – 2016. – V. 23. – P. 1–5. DOI: 10.1186/s12929-016-0253-4.
21. Wang X.F. et al. Biological mechanisms of premature ovarian failure caused by psychological stress based on support vector regression // International Journal of Clinical and Experimental Medicine. – 2015. – V. 8. – No 11. – P. 21393.
22. Fedoce A.G. et al. The role of oxidative stress in anxiety disorder: cause or consequence? // Free Radical Research. – 2018. – V. 52. – No 7. – P. 737–750. DOI: 10.1080/10715762.2018.1475733.
23. Palta P. et al. Depression and oxidative stress: results from a meta-analysis of observational studies // Psychosomatic medicine. – 2014. – V. 76. – No 1. – P. 12. DOI: 10.1097/PSY.0000000000000009.
24. Shi Y.Q. et al. Premature ovarian insufficiency: a review on the role of oxidative stress and the application of antioxidants // Frontiers in Endocrinology. – 2023. – V. 14. DOI: 10.3389/fendo.2023.1172481.
25. Sun J. et al. Chronic and cumulative adverse life events in women with primary ovarian insufficiency: an exploratory qualitative study // Frontiers in Endocrinology. – 2022. – V. 13. – P. 856044. DOI: 10.3389/fendo.2022.856044.
26. Allshouse A.A. et al. Evidence for prolonged and unique amenorrhea-related symptoms in women with premature ovarian failure/primary ovarian insufficiency // Menopause. – 2015. – V. 22. – No 2. – P. 166–174. DOI: 10.1097/GME.0000000000000286.
27. Colzato L.S. et al. Effects of estrogen on higher-order cognitive functions in unstressed human females may depend on individual variation in dopamine baseline levels // Frontiers in Neuroscience. – 2014. – V. 8. – P. 65. DOI: 10.3389/fnins.2014.00065.
28. Almey A. et al. Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females // Hormones and Behavior. – 2015. – V. 74. – P. 125–138. DOI: 10.1016/j.yhbeh.2015.06.010.
29. Jacobs E. et al. Estrogen shapes dopamine-dependent cognitive processes: implications for women’s health // Journal of Neuroscience. – 2011. – V. 31. – No 14. – P. 5286–5293. DOI: 10.1523/JNEUROSCI.6394-10.2011.
30. McEwen B.S. et al. Estrogen effects on the brain: actions beyond the hypothalamus via novel mechanisms // Behavioral neuroscience. – 2012. – V. 126. – No 1. – P. 4. DOI: 10.1037/a0026708.
31. Brinton R.D. et al. Perimenopause as a neurological transition state // Nature Reviews Endocrinology. – 2015. – V. 11. – No 7. – P. 393–405. DOI: 10.1038/nrendo.2015.82.
32. Farrag A.F. et al. Effect of surgical menopause on cognitive functions // Dementia and Geriatric Cognitive Disorders. – 2002. – V. 13. – No 3. – P. 193–198. DOI: 10.1159/000048652.
33. Bove R. et al. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women // Neurology. – 2014. – V. 82. – No 3. – P. 222–229. DOI: 10.1212/WNL.0000000000000033.
34. Holschneider D. P. et al. Tissue-specific effects of estrogen on monoamine oxidase A and B in the rat // Life Sciences. – 1998. – V. 63. – No 3. – P. 155–160. DOI: 10.1016/s0024-3205(98)00255-0.
35. Xi D. et al. The risk of depressive and anxiety symptoms in women with premature ovarian insufficiency: a systematic review and meta-analysis // Archives of Women’s Mental Health. – 2023. – V. 26. – No 1. – P. 1–10. DOI: 10.1007/s00737-022-01289-7.
36. Riecher-Rössler A. et al. Schizophrenia and oestrogens: is there an association? // European Archives of Psychiatry and Clinical Neuroscience. – 1993. – V. 242. – P. 323–328. DOI: 10.1007/BF02190244.
37. Seeman M.V. The role of estrogen in schizophrenia // Journal of Psychiatry and Neuroscience. – 1996. – V. 21. – No 2. – P. 123.
38. Häfner H. et al. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia // Psychological Medicine. – 1993. – V. 23. – No 4. – P. 925–940. DOI: 10.1017/s0033291700026398.
39. Reilly T.J. et al. Exacerbation of psychosis during the perimenstrual phase of the menstrual cycle: systematic review and meta-analysis // Schizophrenia Bulletin. – 2020. – V. 46. – No 1. – P. 78-90. DOI: 10.1093/schbul/sbz030.
40. Krafft-Ebing R. Psychosis menstrualis; eine klinisch-forensische Studie. – Enke, 1902. [Krafft-Ebing R. Psychosis menstrualis: a clinical forensic study. – Enke, 1902. In German].
41. Марченко Л.А. и др. Ведение женщин со своевременной и преждевременной менопаузой // Казанский медицинский журнал. – 2008. – Т. 89. – № 1. – С. 43–46. [Marchenko L.A. et al. Treatment of women with timely and anticipatory menopause // Kazan Medical Journal. – 2008. – V. 89. – No 1. – P. 43–46. In Russian].
42. Maciejewska-Jeske M. et al. Consequences of premature ovarian insufficiency on women’s sexual health // Menopause Review / Przegląd Menopauzalny. – 2018. – V. 17. – No 3. – P. 127–130. DOI: 10.5114/pm.2018.78557.
43. Nelson L.M. Primary ovarian insufficiency // New England Journal of Medicine. – 2009. – V. 360. – No 6. – P. 606–614. DOI: 10.1056/NEJMcp0808697.
44. Fraison E. et al. Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review // Reproductive Biomedicine Online. – 2019. – V. 39. – No 3. – P. 467–476. DOI: 10.1016/j.rbmo.2019.04.019.
45. Cousineau T. M., Domar A. D. Psychological impact of infertility // Best Practice & Research Clinical Obstetrics & Gynaecology. – 2007. – V. 21. – No 2. – P. 293-308. DOI: 10.1016/j.bpobgyn.2006.12.003.
46. Rooney K.L. et al. The relationship between stress and infertility // Dialogues in Clinical Neuroscience. – 2018. – V. 20. – No 1. – P. 41–47. DOI: 10.31887/DCNS.2018.20.1/klrooney.
47. Williams K.E. et al. Mood disorders and fertility in women: a critical review of the literature and implications for future research // Human Reproduction Update. – 2007. – V. 13. – No 6. – P. 607–616. DOI: 10.1093/humupd/dmm019.
48. Chen T.H. et al. Prevalence of depressive and anxiety disorders in an assisted reproductive technique clinic // Human Reproduction. – 2004. – V. 19. – No 10. – P. 2313–2318. DOI: 10.1093/humrep/deh414.
49. Блинов Д.В. и др. Ранняя менопауза и преждевременная недостаточность яичников: проблемы и перспективы // Акушерство, гинекология и репродукция. – 2020. – Т. 14. – № 3. – С. 328–345. [Blinov D.V. et al. Early menopause and premature ovarian insufficiency: problems and perspectives // Obstetrics, Gynecology and Reproduction. – 2020. – V. 14. – No 3. – P. 328–345. In Russian]. DOI: 10.17749/2313-7347/ob.gyn.rep.2020.173.
50. Sullivan S.D. et al. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause // Fertility and Sterility. – 2016. – V. 106. – No 7. – P. 1588–1599. DOI: 10.1016/j.fertnstert.2016.09.046.
51. Kling J.M. et al. Association of sleep disturbance and sexual function in postmenopausal women // Menopause. – 2017. – V. 24. – No 6. – P. 604–612. DOI: 10.1097/GME.0000000000000824.
52. Rabijewski M. et al. Supplementation of dehydroepiandrosterone (DHEA) in pre-and postmenopausal women – position statement of expert panel of polish menopause and andropause society // Ginekologia Polska. – 2020. – V. 91. – No 9. – P. 554–562. DOI: 10.5603/GP.2020.0091.
53. Guerrieri G.M. et al. Effects of physiologic testosterone replacement on quality of life, self-esteem, and mood in women with primary ovarian insufficiency // Menopause (New York, NY). – 2014. – V. 21. – No 9. – P. 952. DOI: 10.1097/GME.0000000000000195.
54. Menezes C. et al. Women with premature ovarian failure using hormone therapy do not experience increased levels of depression, anxiety and stress compared to controls // Journal of Affective Disorders. – 2020. – V. 273. – P. 562–566. DOI: 10.1016/j.jad.2020.05.105.
55. Gordon J.L. et al. Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial // JAMA psychiatry. – 2018. – V. 75. – No 2. – P. 149–157. DOI: 10.1001/jamapsychiatry.2017.3998.
56. Liu P. et al. Menopausal depression: comparison of hormone replacement therapy and hormone replacement therapy plus fluoxetine // Chinese Medical Journal. – 2004. – V. 117. – No 2. – P. 189–194.
57. Graziottin A. et al. Depression and the menopause: why antidepressants are not enough? // Menopause international. – 2009. – V. 15. – No 2. – P. 76–81. DOI: 10.1258/mi.2009.009021.
58. Soares C. N. Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management // Drugs & Aging. – 2013. – V. 30. – No 9. – P. 677–685. DOI: 10.1007/s40266-013-0100-1.
2. Golezar S. et al. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis // Climacteric. – 2019. – V. 22. – No 4. – P. 403–411. DOI: 10.1080/13697137.2019.1574738.
3. Дубкова Е.А. и др. Влияние комбинированных оральных контрацептивов на уровень антимюллерова гормона в патогенезе преждевременного истощения яичников // Journal of Siberian Medical Sciences. – 2014. – № 3. – С. 75. [Dubkova E.A. et al. Influence of combined oral contraceptives on the hormone anti-mullerian level in pathogenesis of premature deterioration of ovaries // Journal of Siberian Medical Sciences. – 2014. – No 3. – P. 75. In Russian].
4. Luborsky J.L. et al. Premature menopause in a multi‐ethnic population study of the menopause transition // Human Reproduction. – 2003. – V. 18. – No 1. – P. 199–206. DOI: 10.1093/humrep/deg005.
5. Van Kasteren Y.M. et al. Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease? // Human Reproduction. – 1999. – V. 14. – No 10. – P. 2455–2459. DOI: 10.1093/humrep/14.10.2455.
6. Семенова Е.В. и др. Этиология женского бесплодия // Современные проблемы медицины и естественных наук. – 2018. – С. 79–83. [Semenova E.V. et al. Ethiology of female infertility // Modern problems of medicine and natural science. – 2018. – P. 79–83. In Russian].
7. Машина М.А. и др. Проблемы изменения репродуктивного поведения и реализации репродуктивной функции // Лечащий врач. – 2014. – № 12. – С. 22–22. [Mashina M.A. et al. Problems of changing reproductive behavior and implementation of reproductive function // Lechaschi vrach. – 2014. – No 12. – P. 22–22. In Russian].
8. Schmidt P.J. et al. Depression in women with spontaneous 46, XX primary ovarian insufficiency // The Journal of Clinical Endocrinology & Metabolism. – 2011. – V. 96. – No 2. – P. E278–E287. DOI: 10.1210/jc.2010-0613.
9. Mann E. et al. Psychosocial adjustment in women with premature menopause: a cross-sectional survey // Climacteric. – 2012. – V. 15. – No 5. – P. 481–489. DOI: 10.3109/13697137.2011.647841.
10. Liao K.L.M. et al. Premature menopause and psychological well-being // Journal of Psychosomatic Obstetrics & Gynecology. – 2000. – V. 21. – No 3. – P. 167–174. DOI: 10.3109/01674820009075624.
11. Deeks A.A. et al. Premature menopause: a comprehensive understanding of psychosocial aspects // Climacteric. – 2011. – V. 14. – No 5. – P. 565–572. DOI: 10.3109/13697137.2011.566390.
12. Домнина О.Л. и др. Анализ экономической значимости психических расстройств // Научные проблемы водного транспорта. – 2018. – No 56. – С. 139–148. [Domnina O.L. et al. Analysis of economic significance of mental disorders // Russian Journal of Water Transport. – 2018. – No 56 – P. 139–148. In Russian].
13. Eshre Guideline Group on POI et al. ESHRE Guideline: management of women with premature ovarian insufficiency // Human Reproduction. – 2016. – V. 31. – No 5. – P. 926–937. DOI: 10.1093/humrep/dew027.
14. Yorgun H. et al. The cardiovascular effects of premature ovarian failure // International Journal of Cardiology. – 2013. – V. 168. – No 1. – С. 506–510. DOI: 10.1016/j.ijcard.2012.09.197.
15. Podfigurna-Stopa A. et al. Premature ovarian insufficiency: the context of long-term effects // Journal of Endocrinological Investigation. – 2016. – V. 39. – P. 983–990. DOI: 10.1007/s40618-016-0467-z.
16. Anagnostis P. et al. Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis // European Journal of Endocrinology. – 2019. – V. 180. – No 1. – P. 41–50. DOI: 10.1530/EJE-18-0602.
17. Lana M.B.P. et al. What is really responsible for bone loss in spontaneous premature ovarian failure? A new enigma // Gynecological Endocrinology. – 2010. – V. 26. – No 10. – P. 755–759. DOI: 10.3109/09513590.2010.487599.
18. Pimple P. et al. Psychological distress and subsequent cardiovascular events in individuals with coronary artery disease // Journal of the American Heart Association. – 2019. – V. 8. – No 9. – P. e011866. DOI: 10.1161/JAHA.118.011866.
19. Tsolaki M. et al. Severe psychological stress in elderly individuals: a proposed model of neurodegeneration and its implications // American Journal of Alzheimer's Disease & Other Dementias®. – 2009. – V. 24. – No 2. – P. 85–94. DOI: 10.1177/1533317508329813.
20. Prasad S. et al. Impact of stress on oocyte quality and reproductive outcome //Journal of Biomedical Science. – 2016. – V. 23. – P. 1–5. DOI: 10.1186/s12929-016-0253-4.
21. Wang X.F. et al. Biological mechanisms of premature ovarian failure caused by psychological stress based on support vector regression // International Journal of Clinical and Experimental Medicine. – 2015. – V. 8. – No 11. – P. 21393.
22. Fedoce A.G. et al. The role of oxidative stress in anxiety disorder: cause or consequence? // Free Radical Research. – 2018. – V. 52. – No 7. – P. 737–750. DOI: 10.1080/10715762.2018.1475733.
23. Palta P. et al. Depression and oxidative stress: results from a meta-analysis of observational studies // Psychosomatic medicine. – 2014. – V. 76. – No 1. – P. 12. DOI: 10.1097/PSY.0000000000000009.
24. Shi Y.Q. et al. Premature ovarian insufficiency: a review on the role of oxidative stress and the application of antioxidants // Frontiers in Endocrinology. – 2023. – V. 14. DOI: 10.3389/fendo.2023.1172481.
25. Sun J. et al. Chronic and cumulative adverse life events in women with primary ovarian insufficiency: an exploratory qualitative study // Frontiers in Endocrinology. – 2022. – V. 13. – P. 856044. DOI: 10.3389/fendo.2022.856044.
26. Allshouse A.A. et al. Evidence for prolonged and unique amenorrhea-related symptoms in women with premature ovarian failure/primary ovarian insufficiency // Menopause. – 2015. – V. 22. – No 2. – P. 166–174. DOI: 10.1097/GME.0000000000000286.
27. Colzato L.S. et al. Effects of estrogen on higher-order cognitive functions in unstressed human females may depend on individual variation in dopamine baseline levels // Frontiers in Neuroscience. – 2014. – V. 8. – P. 65. DOI: 10.3389/fnins.2014.00065.
28. Almey A. et al. Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females // Hormones and Behavior. – 2015. – V. 74. – P. 125–138. DOI: 10.1016/j.yhbeh.2015.06.010.
29. Jacobs E. et al. Estrogen shapes dopamine-dependent cognitive processes: implications for women’s health // Journal of Neuroscience. – 2011. – V. 31. – No 14. – P. 5286–5293. DOI: 10.1523/JNEUROSCI.6394-10.2011.
30. McEwen B.S. et al. Estrogen effects on the brain: actions beyond the hypothalamus via novel mechanisms // Behavioral neuroscience. – 2012. – V. 126. – No 1. – P. 4. DOI: 10.1037/a0026708.
31. Brinton R.D. et al. Perimenopause as a neurological transition state // Nature Reviews Endocrinology. – 2015. – V. 11. – No 7. – P. 393–405. DOI: 10.1038/nrendo.2015.82.
32. Farrag A.F. et al. Effect of surgical menopause on cognitive functions // Dementia and Geriatric Cognitive Disorders. – 2002. – V. 13. – No 3. – P. 193–198. DOI: 10.1159/000048652.
33. Bove R. et al. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women // Neurology. – 2014. – V. 82. – No 3. – P. 222–229. DOI: 10.1212/WNL.0000000000000033.
34. Holschneider D. P. et al. Tissue-specific effects of estrogen on monoamine oxidase A and B in the rat // Life Sciences. – 1998. – V. 63. – No 3. – P. 155–160. DOI: 10.1016/s0024-3205(98)00255-0.
35. Xi D. et al. The risk of depressive and anxiety symptoms in women with premature ovarian insufficiency: a systematic review and meta-analysis // Archives of Women’s Mental Health. – 2023. – V. 26. – No 1. – P. 1–10. DOI: 10.1007/s00737-022-01289-7.
36. Riecher-Rössler A. et al. Schizophrenia and oestrogens: is there an association? // European Archives of Psychiatry and Clinical Neuroscience. – 1993. – V. 242. – P. 323–328. DOI: 10.1007/BF02190244.
37. Seeman M.V. The role of estrogen in schizophrenia // Journal of Psychiatry and Neuroscience. – 1996. – V. 21. – No 2. – P. 123.
38. Häfner H. et al. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia // Psychological Medicine. – 1993. – V. 23. – No 4. – P. 925–940. DOI: 10.1017/s0033291700026398.
39. Reilly T.J. et al. Exacerbation of psychosis during the perimenstrual phase of the menstrual cycle: systematic review and meta-analysis // Schizophrenia Bulletin. – 2020. – V. 46. – No 1. – P. 78-90. DOI: 10.1093/schbul/sbz030.
40. Krafft-Ebing R. Psychosis menstrualis; eine klinisch-forensische Studie. – Enke, 1902. [Krafft-Ebing R. Psychosis menstrualis: a clinical forensic study. – Enke, 1902. In German].
41. Марченко Л.А. и др. Ведение женщин со своевременной и преждевременной менопаузой // Казанский медицинский журнал. – 2008. – Т. 89. – № 1. – С. 43–46. [Marchenko L.A. et al. Treatment of women with timely and anticipatory menopause // Kazan Medical Journal. – 2008. – V. 89. – No 1. – P. 43–46. In Russian].
42. Maciejewska-Jeske M. et al. Consequences of premature ovarian insufficiency on women’s sexual health // Menopause Review / Przegląd Menopauzalny. – 2018. – V. 17. – No 3. – P. 127–130. DOI: 10.5114/pm.2018.78557.
43. Nelson L.M. Primary ovarian insufficiency // New England Journal of Medicine. – 2009. – V. 360. – No 6. – P. 606–614. DOI: 10.1056/NEJMcp0808697.
44. Fraison E. et al. Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review // Reproductive Biomedicine Online. – 2019. – V. 39. – No 3. – P. 467–476. DOI: 10.1016/j.rbmo.2019.04.019.
45. Cousineau T. M., Domar A. D. Psychological impact of infertility // Best Practice & Research Clinical Obstetrics & Gynaecology. – 2007. – V. 21. – No 2. – P. 293-308. DOI: 10.1016/j.bpobgyn.2006.12.003.
46. Rooney K.L. et al. The relationship between stress and infertility // Dialogues in Clinical Neuroscience. – 2018. – V. 20. – No 1. – P. 41–47. DOI: 10.31887/DCNS.2018.20.1/klrooney.
47. Williams K.E. et al. Mood disorders and fertility in women: a critical review of the literature and implications for future research // Human Reproduction Update. – 2007. – V. 13. – No 6. – P. 607–616. DOI: 10.1093/humupd/dmm019.
48. Chen T.H. et al. Prevalence of depressive and anxiety disorders in an assisted reproductive technique clinic // Human Reproduction. – 2004. – V. 19. – No 10. – P. 2313–2318. DOI: 10.1093/humrep/deh414.
49. Блинов Д.В. и др. Ранняя менопауза и преждевременная недостаточность яичников: проблемы и перспективы // Акушерство, гинекология и репродукция. – 2020. – Т. 14. – № 3. – С. 328–345. [Blinov D.V. et al. Early menopause and premature ovarian insufficiency: problems and perspectives // Obstetrics, Gynecology and Reproduction. – 2020. – V. 14. – No 3. – P. 328–345. In Russian]. DOI: 10.17749/2313-7347/ob.gyn.rep.2020.173.
50. Sullivan S.D. et al. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause // Fertility and Sterility. – 2016. – V. 106. – No 7. – P. 1588–1599. DOI: 10.1016/j.fertnstert.2016.09.046.
51. Kling J.M. et al. Association of sleep disturbance and sexual function in postmenopausal women // Menopause. – 2017. – V. 24. – No 6. – P. 604–612. DOI: 10.1097/GME.0000000000000824.
52. Rabijewski M. et al. Supplementation of dehydroepiandrosterone (DHEA) in pre-and postmenopausal women – position statement of expert panel of polish menopause and andropause society // Ginekologia Polska. – 2020. – V. 91. – No 9. – P. 554–562. DOI: 10.5603/GP.2020.0091.
53. Guerrieri G.M. et al. Effects of physiologic testosterone replacement on quality of life, self-esteem, and mood in women with primary ovarian insufficiency // Menopause (New York, NY). – 2014. – V. 21. – No 9. – P. 952. DOI: 10.1097/GME.0000000000000195.
54. Menezes C. et al. Women with premature ovarian failure using hormone therapy do not experience increased levels of depression, anxiety and stress compared to controls // Journal of Affective Disorders. – 2020. – V. 273. – P. 562–566. DOI: 10.1016/j.jad.2020.05.105.
55. Gordon J.L. et al. Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial // JAMA psychiatry. – 2018. – V. 75. – No 2. – P. 149–157. DOI: 10.1001/jamapsychiatry.2017.3998.
56. Liu P. et al. Menopausal depression: comparison of hormone replacement therapy and hormone replacement therapy plus fluoxetine // Chinese Medical Journal. – 2004. – V. 117. – No 2. – P. 189–194.
57. Graziottin A. et al. Depression and the menopause: why antidepressants are not enough? // Menopause international. – 2009. – V. 15. – No 2. – P. 76–81. DOI: 10.1258/mi.2009.009021.
58. Soares C. N. Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management // Drugs & Aging. – 2013. – V. 30. – No 9. – P. 677–685. DOI: 10.1007/s40266-013-0100-1.